Take, for example, Dr. Herbert Kleber of Columbia University. Kleber has impeccable academic credentials, and has been quoted in the press and in academic publications warning against the use of marijuana, which he stresses may cause wide-ranging addiction and public health issues. But when he's writing anti-pot opinion pieces for CBS News, or being quoted by NPR and CNBC, what's left unsaid is that Kleber has served as a paid consultant to leading prescription drug companies, including Purdue Pharma (the maker of OxyContin), Reckitt Benckiser (the producer of a painkiller called Nurofen), and Alkermes (the producer of a powerful new opioid called Zohydro).

Kleber, who did not respond to a request for comment, maintains important influence over the pot debate. For instance, his writing has been cited by the New York State Association of Chiefs of Police in its opposition to marijuana legalization, and has been published by the American Psychiatric Association in the organization's statement warning against marijuana for medicinal uses.

 

Read the rest, here.

Not suprising in the slightest.  It's also how the DuPont family still remains in some forms one of the largest contributers to the war on marijuana due to hemp's ability to greatly affect the petrochemical industry (and dupont's pockets)

This doesn't surprised me at all,actually.

I've seen the lengths ppl will go for narcotics

Conflict of interest for sure. Seems to be a going thing lately.

I dont even need to read the article.

Marijuana is a plant, not a drug. Many many many pills will not be needed soon, when it is legal. I really feel we will see it within the next decade.